April 11, 2016

Analysis of Follicum AB published

An analysis of Follicum AB, conducted by the Swedish Shareholders’ Association, has been published today. The document is only available in Swedish. >Anaysis of Follicum (in Swedish) For more information, please contact: Jan Alenfall, CEO Tel: +46 (0)46 19 21 97 Email:

March 9, 2016

Follicum will present at Sedermeradagen

On 16 March, CEO Jan Alenfall will present Follicum at Sedermeradagen in Lund at 16.20-16.50. Sedermeradagen  offers an opportunity for investors to meet with companies in the micro- and smallcap segment in Sweden. More information in Swedish

December 21, 2015

Follicum Appoints Director R&D

Follicum appoints Maria Ekblad Director R&D as of January 2016. Maria Ekblad has more than twenty years of experience from the  pharmaceutical industry where she has held various management positions; the latest as Director Preclinical Development at Active Biotech AB in Lund. At Follicum Ekblad will be responsible for the preclinical development as well as […]

November 30, 2015

Report from World Conference on Hair Research 2015

Follicum report from World Conference on Hair Research, November 18-21, 2015 in Miami, USA by CEO Jan Alenfall The 2015 WCHR Scientific meeting has the overall goal of presenting new research, sharing experiences, and discussing the advancement and knowledge of hair growth as well as skin-, hair- and scalp diseases. In addition it is a […]

October 26, 2015

French Swedish Life Science Day 2015

Follicum attended the  French Swedish Life  Science  Day 2015  on 20 October in Paris.  The company presented their research projects and had the opportunity to meet with investors and representatives from pharmaceutical companies. The purpose of the meetings was to initiate contacts for future capital investments and potential collaborations. There was significant interest in Follicum’s drug candidates.

October 1, 2015

Follicum’s patent preliminary approved

Follicum has received a preliminary approval – a so called “Intention to Grant” – by the European Patent Office (EPO) regarding the company’s patent application for stimulation of hair growth. To read the full press release (in Swedish) please click here. For more information about Follicum’s research results, please contact: Jan Alenfall, CEO Tel +46 (0)46 19 21 […]

September 9, 2015

Cooperation initiated with research group in Berlin for the planned clinical study

As previously communicated, Follicum’s intention is to start a clinical phase I/IIa study around year-end 2015/early 2016. We can now announce that a cooperation with the Clinical Research Center for Hair and Skin Science (“CRC”) in Berlin, Germany, has been initiated regarding our planned clinical phase I/IIa study. Follicum’s intention is to submit an application […]

September 1, 2015

Follicum has completed toxicity studies

Follicum announced in March 2015  that they had started two larger toxicity studies to  add information to the two short time toxicity studies and  continue development. The short time studies were finalized in February 2015, and showed no adverse effects. The two larger toxicity studies have now been finished according to plan, showing very promising […]